Corewell Health in Royal Oak says it has performed the world’s first single-port robotic mitral valve repair, a procedure ...

Add Yahoo as a preferred source to see more of our stories on Google. Mary Ann George had a question for Dr. George D'Angelo, shortly after the groundbreaking Erie heart surgeon replaced two of her ...

The patient had previously undergone heart valve replacement but later developed severe tricuspid regurgitation ...

People having surgery to repair tight or leaking heart valves may receive a pacemaker more often than necessary—leading to a greater risk for life-threatening complications, studies show. It's common ...

Surgery is usually the best fix for a severe heart valve disease. Different types of heart valve blockages can happen, and surgery is necessary to fix these problems. Your heart is split into four ...

A study reveals that preserving the heart valve during aortic surgery leads to better long-term survival for patients in India.

MGM Healthcare successfully performs complex mitral valve replacement surgery on a 14-year-old girl with rare heart ...

A grandmother has been given a “second chance at life” after undergoing a world-first heart valve operation. Julia Butterworth, 53, had two valves in her heart replaced in 2007 after doctors detected ...

Edoxaban, an oral anticoagulant, was equally or more effective than warfarin in reducing the risk of stroke and blood clots for patients after heart valve replacement surgery, according to preliminary ...

Heart valve disease happens when one or more of your heart’s four valves don’t work properly, preventing oxygen-rich blood from moving efficiently through your heart and to your body. This forces your ...

Bicuspid aortic valve surgery involves repairing or replacing a bicuspid valve. The procedure corrects a congenital condition in which a person has two cusps instead of three. A bicuspid aortic valve ...

A common cause of heart failure in elderly people is a defective heart valve, but open-heart surgery to correct the problem may be too risky for some patients. A new clinical trial at Duke University ...